ETF comparison

VHT vs XBI

Both Healthcare.

Vanguard Health Care Index Fund ETF Shares · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
12.7 %

133 positions appear in both funds. Buying equal dollars of VHT and XBI would leave roughly 12.7% of each dollar exposed to the same underlying securities.

VHT only 87.0% Shared 12.7% XBI only 87.3%
In VHT only
275 positions
Shared
133 positions
In XBI only
21 positions

Side by side

VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$20.39B
TTM yield
1.58%
Top-10 conc.
50.3%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81 composite / 100
Expense ratio
0.35%
Net assets
$10.73B
TTM yield
0.37%
Top-10 conc.
20.4%

Sub-score comparison

91
Cost
65
82
Tax efficiency
85
100
Liquidity
100
42
Concentration
85
Tracking quality
VHT sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

VHT is 26 bps cheaper than XBI. On a $100,000 position that's about $260/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with VHT vs XBI.

Top shared holdings

133 shared in total
# Holding In VHT In XBI Overlap
1 Regeneron Pharmaceuticals Inc 1.21% 1.14% 1.14%
2 AbbVie Inc 6.08% 1.09% 1.09%
3 Gilead Sciences Inc 2.74% 1.09% 1.09%
4 Amgen Inc 3.10% 1.06% 1.06%
5 Vertex Pharmaceuticals Inc 1.89% 1.03% 1.03%
6 Alnylam Pharmaceuticals Inc 0.65% 1.18% 0.65%
7 Insmed Inc 0.47% 1.34% 0.47%
8 Biogen Inc 0.42% 1.10% 0.42%
9 Natera Inc 0.40% 1.16% 0.40%
10 United Therapeutics Corp 0.32% 1.24% 0.32%
11 Incyte Corp 0.25% 1.13% 0.25%
12 Moderna Inc 0.24% 1.03% 0.24%

Only in VHT

275 total
  • Eli Lilly & Co 12.54%
  • Johnson & Johnson 8.74%
  • Merck & Co Inc 4.58%
  • UnitedHealth Group Inc 3.94%
  • Abbott Laboratories 3.00%
  • Thermo Fisher Scientific Inc 2.92%
  • Intuitive Surgical Inc 2.68%
  • Pfizer Inc 2.33%
  • Danaher Corp 2.01%
  • Stryker Corp 1.98%

Only in XBI

21 total
  • CRISPR Therapeutics AG 1.09%
  • Capricor Therapeutics Inc 0.48%
  • uniQure NV 0.37%
  • Inhibrx Biosciences Inc 0.27%
  • SELLAS Life Sciences Group Inc 0.27%
  • Compass Therapeutics Inc 0.26%
  • Rigel Pharmaceuticals Inc 0.26%
  • Sionna Therapeutics Inc 0.22%
  • Vor BioPharma Inc 0.22%
  • Absci Corp 0.18%

Open VHT or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.